Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) reports Q1 EPS of $(0.09) versus the estimated $(0.08), missing by $0.01. EPS were Up 25% from the same quarter last year. Revenue came in at $16.50M versus the estimated $16.42M. Sales were Up 130% year over year
now how did they miss by 1 est was .08 and they earned .09 ps.